Oxford American Handbook of Oncology
Herausgeber: Lyman, Gary H
Oxford American Handbook of Oncology
Herausgeber: Lyman, Gary H
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
The Oxford American Handbook of Oncology is the essential ready reference for medical students, residents, and clinical oncologists seeking a current, portable resource on the delivery of sophisticated cancer care. Biologic therapies and therapeutic regimens and options and clinical trial information have been rigorously updated for the new edition.
Andere Kunden interessierten sich auch für
- Gary LymanOxford American Mini-Handbook of Cancer Supportive Care47,99 €
- Kevin BrownOxford American Handbook of Pulmonary Medicine83,99 €
- David L BergerOxford American Handbook of Surgery83,99 €
- Gary LymanOxford American Mini-Handbook of Hematologic Malignancies46,99 €
- Oxford American Handbook of Cardiology97,99 €
- Aimee ZaasOxford American Handbook of Infectious Diseases105,99 €
- Oxford American Handbook of Clinical Medicine (Revised)102,99 €
-
-
-
The Oxford American Handbook of Oncology is the essential ready reference for medical students, residents, and clinical oncologists seeking a current, portable resource on the delivery of sophisticated cancer care. Biologic therapies and therapeutic regimens and options and clinical trial information have been rigorously updated for the new edition.
Produktdetails
- Produktdetails
- Verlag: Oxford University Press, USA
- 2nd Revised edition
- Seitenzahl: 864
- Erscheinungstermin: 25. Februar 2015
- Englisch
- Abmessung: 180mm x 102mm x 46mm
- Gewicht: 540g
- ISBN-13: 9780199922789
- ISBN-10: 0199922780
- Artikelnr.: 42436474
- Verlag: Oxford University Press, USA
- 2nd Revised edition
- Seitenzahl: 864
- Erscheinungstermin: 25. Februar 2015
- Englisch
- Abmessung: 180mm x 102mm x 46mm
- Gewicht: 540g
- ISBN-13: 9780199922789
- ISBN-10: 0199922780
- Artikelnr.: 42436474
Gary H Lyman: Co-Director, Hutchinson Institute for Cancer Outcomes Research; Affiliate Professor, University of Washington Schools of Public Health and Pharmacy, Seattle, WA
* Part 1 Background
* 1 Molecular cancer biology
* 2 Etiology and epidemiology
* Part 2 Cancer prevention and screening
* 3 Cancer prevention
* 4 Cancer screening
* 5 Genetic screening
* Part 3 Principles of management
* 6 Principles of cancer treatment
* 7 Surgical oncology
* 8 Principles of radiation oncology
* 9 Principles of chemotherapy
* 10 Hematopoietic stem cell transplantation
* 11 Hormone therapy
* 12 Targeted therapies
* 13 Gene therapy and immunotherapy for cancer
* 14 Complementary and alternative medicine
* 15 Clinical trials
* Part 4 Complications and supportive care
* 16 Anemia and fatigue
* 17 Febrile neutropenia
* 18 Pain management
* 19 Venous thromboembolism
* 20 Metabolic emergencies
* 21 Paraneoplastic syndromes
* 22 Superior vena cava syndrome and raised intracranial pressure
* 23 Spinal cord compression
* 24 Other obstructive complications
* 25 Late effects of cancer treatment
* 26 End-of-life care
* Part 5 Specific cancers
* 27 Thoracic cancers
* 28 Breast cancer
* 29 Gastrointestinal cancer I: esophagus, stomach, small intestine,
carcinoid
* 30 Gastrointestinal cancer II: pancreas, biliary tract,
hepatocellular
* 31 Gastrointestinal cancer III: colorectal, anus
* 32 Endocrine cancers
* 33 Genitourinary cancer I: renal, bladder, ureter, penile carcinomas
* 34 Genitourinary cancer II: prostate cancer
* 35 Genitourinary cancer III: testicular cancer
* 36 Gynecological cancer
* 37 Tumors of the central nervous system
* 38 Head and neck cancers
* 39 Cutaneous malignancies
* 40 Soft tissue and bone sarcomas
* 41 Acute leukemia
* 42 Chronic leukemias and myelodysplastic syndromes
* 43 Multiple myeloma
* 44 Malignant lymphoma
* 45 Cancer of unknown primary (CUP)
* Appendix
* 1 Molecular cancer biology
* 2 Etiology and epidemiology
* Part 2 Cancer prevention and screening
* 3 Cancer prevention
* 4 Cancer screening
* 5 Genetic screening
* Part 3 Principles of management
* 6 Principles of cancer treatment
* 7 Surgical oncology
* 8 Principles of radiation oncology
* 9 Principles of chemotherapy
* 10 Hematopoietic stem cell transplantation
* 11 Hormone therapy
* 12 Targeted therapies
* 13 Gene therapy and immunotherapy for cancer
* 14 Complementary and alternative medicine
* 15 Clinical trials
* Part 4 Complications and supportive care
* 16 Anemia and fatigue
* 17 Febrile neutropenia
* 18 Pain management
* 19 Venous thromboembolism
* 20 Metabolic emergencies
* 21 Paraneoplastic syndromes
* 22 Superior vena cava syndrome and raised intracranial pressure
* 23 Spinal cord compression
* 24 Other obstructive complications
* 25 Late effects of cancer treatment
* 26 End-of-life care
* Part 5 Specific cancers
* 27 Thoracic cancers
* 28 Breast cancer
* 29 Gastrointestinal cancer I: esophagus, stomach, small intestine,
carcinoid
* 30 Gastrointestinal cancer II: pancreas, biliary tract,
hepatocellular
* 31 Gastrointestinal cancer III: colorectal, anus
* 32 Endocrine cancers
* 33 Genitourinary cancer I: renal, bladder, ureter, penile carcinomas
* 34 Genitourinary cancer II: prostate cancer
* 35 Genitourinary cancer III: testicular cancer
* 36 Gynecological cancer
* 37 Tumors of the central nervous system
* 38 Head and neck cancers
* 39 Cutaneous malignancies
* 40 Soft tissue and bone sarcomas
* 41 Acute leukemia
* 42 Chronic leukemias and myelodysplastic syndromes
* 43 Multiple myeloma
* 44 Malignant lymphoma
* 45 Cancer of unknown primary (CUP)
* Appendix
* Part 1 Background
* 1 Molecular cancer biology
* 2 Etiology and epidemiology
* Part 2 Cancer prevention and screening
* 3 Cancer prevention
* 4 Cancer screening
* 5 Genetic screening
* Part 3 Principles of management
* 6 Principles of cancer treatment
* 7 Surgical oncology
* 8 Principles of radiation oncology
* 9 Principles of chemotherapy
* 10 Hematopoietic stem cell transplantation
* 11 Hormone therapy
* 12 Targeted therapies
* 13 Gene therapy and immunotherapy for cancer
* 14 Complementary and alternative medicine
* 15 Clinical trials
* Part 4 Complications and supportive care
* 16 Anemia and fatigue
* 17 Febrile neutropenia
* 18 Pain management
* 19 Venous thromboembolism
* 20 Metabolic emergencies
* 21 Paraneoplastic syndromes
* 22 Superior vena cava syndrome and raised intracranial pressure
* 23 Spinal cord compression
* 24 Other obstructive complications
* 25 Late effects of cancer treatment
* 26 End-of-life care
* Part 5 Specific cancers
* 27 Thoracic cancers
* 28 Breast cancer
* 29 Gastrointestinal cancer I: esophagus, stomach, small intestine,
carcinoid
* 30 Gastrointestinal cancer II: pancreas, biliary tract,
hepatocellular
* 31 Gastrointestinal cancer III: colorectal, anus
* 32 Endocrine cancers
* 33 Genitourinary cancer I: renal, bladder, ureter, penile carcinomas
* 34 Genitourinary cancer II: prostate cancer
* 35 Genitourinary cancer III: testicular cancer
* 36 Gynecological cancer
* 37 Tumors of the central nervous system
* 38 Head and neck cancers
* 39 Cutaneous malignancies
* 40 Soft tissue and bone sarcomas
* 41 Acute leukemia
* 42 Chronic leukemias and myelodysplastic syndromes
* 43 Multiple myeloma
* 44 Malignant lymphoma
* 45 Cancer of unknown primary (CUP)
* Appendix
* 1 Molecular cancer biology
* 2 Etiology and epidemiology
* Part 2 Cancer prevention and screening
* 3 Cancer prevention
* 4 Cancer screening
* 5 Genetic screening
* Part 3 Principles of management
* 6 Principles of cancer treatment
* 7 Surgical oncology
* 8 Principles of radiation oncology
* 9 Principles of chemotherapy
* 10 Hematopoietic stem cell transplantation
* 11 Hormone therapy
* 12 Targeted therapies
* 13 Gene therapy and immunotherapy for cancer
* 14 Complementary and alternative medicine
* 15 Clinical trials
* Part 4 Complications and supportive care
* 16 Anemia and fatigue
* 17 Febrile neutropenia
* 18 Pain management
* 19 Venous thromboembolism
* 20 Metabolic emergencies
* 21 Paraneoplastic syndromes
* 22 Superior vena cava syndrome and raised intracranial pressure
* 23 Spinal cord compression
* 24 Other obstructive complications
* 25 Late effects of cancer treatment
* 26 End-of-life care
* Part 5 Specific cancers
* 27 Thoracic cancers
* 28 Breast cancer
* 29 Gastrointestinal cancer I: esophagus, stomach, small intestine,
carcinoid
* 30 Gastrointestinal cancer II: pancreas, biliary tract,
hepatocellular
* 31 Gastrointestinal cancer III: colorectal, anus
* 32 Endocrine cancers
* 33 Genitourinary cancer I: renal, bladder, ureter, penile carcinomas
* 34 Genitourinary cancer II: prostate cancer
* 35 Genitourinary cancer III: testicular cancer
* 36 Gynecological cancer
* 37 Tumors of the central nervous system
* 38 Head and neck cancers
* 39 Cutaneous malignancies
* 40 Soft tissue and bone sarcomas
* 41 Acute leukemia
* 42 Chronic leukemias and myelodysplastic syndromes
* 43 Multiple myeloma
* 44 Malignant lymphoma
* 45 Cancer of unknown primary (CUP)
* Appendix